GE HealthCare Technologies Inc.
GEHCLast close · Oct 16, 202669.57−0.78 (−1.11%)
Market cap$31.4B
4 firms' latest targets, last 90 days: median $84.50 ($79.00–$93.00), 21% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-06 | Barclays | $85.00 | ▲ 9% | +22% |
| 2026-09-22 | Needham | $93.00 | — | +34% |
| 2026-07-30 | Evercore ISI | $84.00 | ▲ 5% | +21% |
| 2026-07-29 | BTIG | $79.00 | ▲ 5% | +14% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $19.6B | +7% | $3.03 | -28% | est. $19.4B+1% | est. $3.82 | 7 |
| 2024reported | $19.7B | +1% | $4.34 | +43% | est. $19.7B+0% | est. $4.30 | 12 |
| 2025reported | $20.6B | +5% | $4.55 | +5% | est. $20.5B+0% | est. $4.55 | 13 |
| 2026 | $21.7B | +5% | $4.92 | +8% | $21.6B–$21.8B | $4.89–$4.99 | 15 |
| 2027 | $22.7B | +5% | $5.43 | +10% | $22.5B–$22.9B | $5.15–$5.58 | 15 |
| 2028 | $23.8B | +5% | $6.04 | +11% | $23.3B–$24.4B | $5.40–$6.40 | 16 |
| 2029 | $25.1B | +5% | $6.67 | +10% | $24.8B–$25.3B | $6.57–$6.76 | 14 |
| 2030 | $26.4B | +5% | $7.30 | +9% | $26.1B–$26.7B | $7.19–$7.40 | 14 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.